MRI与4DCT联合指导勾画原发性肝癌患者放疗靶区初步研究*

doi:10.3969/j.issn.1672-5069.2022.04.028

摘要/Abstract

摘要： 目的探讨磁共振成像(MRI)与四维计算机断层扫描(4DCT)图像联合用于原发性肝癌(PLC)患者首次放疗靶区勾画的价值。方法 2019年5月～2021年5月我院收治的56例PLC患者,在放射治疗前,分别行MRI和4DCT检查,将获得的图像上传至工作站,在自动配准结束后以Reg Reveal和Reg Refine行配准和图像质量评估,锁定局部感兴趣区。比较配准前后4DCT不同时相图像中的肿瘤靶区体积、大体内靶区体积,观察T2加权像(MR-T2)图像与4DCT图像配准精度。结果在4DCT配准后, CT₀₀、CT₁₀、CT₂₀、CT₃₀、CT₄₀、CT₅₀、CT₆₀、CT₇₀、CT₈₀和CT₉₀肿瘤靶区体积分别为(389.8±52.5)cm³、(393.4±59.7)cm³、(390.7±50.3)cm³、(388.5±47.8)cm³、(380.4±40.5)cm³、(379.2±40.6)cm³、(383.7±43.3)cm³、(380.2±41.7)cm³、(371.0±38.9)cm³和(381.7±36.6)cm³,均显著大于配准前【分别为(365.7±29.0)cm³、(360.5±29.2)cm³、(347.4±24.9)cm³、(350.2±27.2)cm³、(351.4±28.5)cm³、(358.4±29.3)cm³、(361.5±34.7)cm³、(357.5±28.8)cm³、(350.3±36.6)cm³和(355.0±34.9)cm³,P＜0.05】;56例PLC患者配准后大体内靶区体积为(468.7±226.2)cm³,显著大于配准前【(410.5±192.5)cm³,P＜0.05】;经门静脉或腹腔干Reg Refine配准后,X、Y、Z轴位移分别为(0.3±0.1)mm、(0.6±0.2)mm和(0.5±0.2)mm,或(0.7±0.2)mm、(0.7±0.3)mm和(0.6±0.2)mm,显著小于自动配准移位【分别为(3.3±0.4)mm、(4.9±0.5)mm和(4.2±0.4)mm或(3.4±0.3)mm、(3.7±0.4)mm和(3.2±0.4)mm,P＜0.05】;MR-T2图像显示肝脏体积为(2002.4±843.7)cm³,4DCT图像显示为(2048.7±937.2)cm³,肝脏体积交叠度为(110.2±22.7)%。结论首次给PLC患者放疗前行MR-T2联合4DCT检查可精确勾画肿瘤靶区,可能提高放疗效果。

关键词: 原发性肝癌, 放疗, 磁共振成像, 四维计算机断层扫描, 勾画靶区, 变形配准

Abstract: Objective The purpose of this study was o evaluate magnetic resonance imaging (MRI)and 4-d computed tomography (4DCT) images in the delineation of target area in patients with primary liver cancer (PLC) undergoingfirst radiotherapy. Methods 56 patients with PLC were admitted to our hospital between May 2019 and May 2021, and all patients tended to receive radiotherapy. Before treatment, the patients underwent MRI and 4DCT examinations respectively, and the images were up-loaded to the workstation. After the automatic registration,the Reg Reveal and Reg Refine were applied for further preciseregistration, the image quality was assessed and local regionof interest (ROI) was locked. The tumor target volume and large body target volume in differentstage of 4DCT images were compared before and after registration. The registration accuracy of T2 weighted image (MR-T2) and 4DCT image was observed. Results After 4DCT registration, the tumor target volume atCT₀₀, CT₁₀, CT₂₀, CT₃₀, CT₄₀, CT₅₀, CT₆₀, CT₇₀, CT₈₀ and CT₉₀ were (389.8±52.5)cm³,(393.4±59.7)cm³,(390.7±50.3)cm³,(388.5±47.8)cm³,(380.4±40.5)cm³,(379.2±40.6)cm³,(383.7±43.3)cm³,(380.2±41.7)cm³,(371.0±38.9)cm³ and (381.7±36.6)cm³, all significantly larger than [(365.7±29.0)cm³,(360.5±29.2)cm³,(347.4±24.9)cm³,(350.2±27.2)cm³,(351.4±28.5)cm³,(358.4±29.3)cm³,(361.5±34.7)cm³,(357.5±28.8)cm³,(350.3±36.6)cm³ and (355.0±34.9)cm³, P＜0.05] before registration; after registration, the large body target volume in the 56 patients with PLC was (468.7±226.2)cm³, significantly larger than [(410.5±192.5)cm³, P＜0.05] before registration; after Reg Refine registration by portal vain or byceliac trunk, the shift at X, Y, Z axis were (0.3±0.1)mm, (0.6±0.2)mm and (0.5±0.2)mm, or (0.7±0.2)mm, (0.7±0.3)mm and (0.6±0.2)mm, all significantly smaller than [(3.3±0.4)mm, (4.9±0.5)mm and (4.2±0.4)mm or (3.4±0.3)mm, (3.7±0.4)mm and (3.2±0.4)mm, respectively, P＜0.05] by automatic registration; the liver volume in MR-T2 image was (2002.4±843.7) cm³, the liver volume in 4DCT image was (2048.7±937.2) cm³, and the overlap of liver volume was (110.2±22.7)%. Conclusion Thecombination of MT-T2 and 4DCT for precise delineation of tumor target in patients withPLC before first radiotherapy could help get accurate tumor targets, which might improve the therapy efficacy.

Key words: Hepatoma, Magnetic resonance imaging, Four-dimensional computed tomography, Radiotherapy, Target delineation, Deformation registration

王远平, 郑露露, 张光亮. MRI与4DCT联合指导勾画原发性肝癌患者放疗靶区初步研究^*[J]. 实用肝脏病杂志, 2022, 25(4): 567-570.

Wang Yuanping, Zheng Lulu, Zhang Guangliang. A pilot study of MR and 4DCT images in the delineation of target area in patients with primary liver cancer undergoing first radiotherapy[J]. Journal of Practical Hepatology, 2022, 25(4): 567-570.

参考文献

[1] Castven D, Becker D, Czauderna C, et al. Application of patient-derived liver cancer cells for phenotypic characterization and therapeutic target identification. Int J Cancer, 2018, 144(11):2782-2794.
[2] Sangro B, Martínez-Urbistondo D, Bester L, et al. Prevention and treatment of complications of selective internal radiation therapy:expert guidance and systematic review. Hepatology, 2017, 66(3):969-982.
[3] 王俊男, 曹飞, 叶小飞,等. 立体定向放疗联合肝动脉化疗栓塞治疗原发性肝癌系统评价和Meta分析. 中华肿瘤防治杂志, 2018, 25(1):66-73.
[4] 陈冬, 王仁本. 原发性肝癌外放疗临床应用现状. 中华肿瘤防治杂志, 2015, 22(1):76-80.
[5] Senthilkumar K, Das M . Comparison of biological-based and dose volume-based intensity-modulated radiotherapy plans generated using the same treatment planning system. JCancer Res Ther, 2019, 15(8):33-38.
[6] Pech M, Mohnike K, Wieners G, et al. Radiotherapy of liver metastases.comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning. Strahlenther Onkol, 2008, 184(5):256-261.
[7] 中华人民共和国卫生部. 原发性肝癌诊疗规范(2011年版). 中华肝脏病杂志, 2012, 20(6):929-946.
[8] Kim D, Medin PM, Timmerman RD . Emphasis on repair, not just avoidance of injury, facilitates prudent stereotactic ablative radiotherapy. Semin Radiat Oncol, 2017, 27(4):378-392.
[9] Niibe Y, Yamashita H, Yamamoto T, et al. O3-3-4stereotactic body radiotherapy for pulmonary oligometastases with emphasis on the difference in oligometastatic state. Ann Oncol, 2015, 26(7):99-99.
[10] Ceniceros L, Aristu J, Castaoon E, et al. Stereotactic body radiotherapy (sbrt) for the treatment of inoperable stage in non-small cell lung cancer patients. Clin Transl Oncol, 2016, 18(3):259-268.
[11] Voroney JP, Brock KK, Eccles C, et al. Prospective comparison of computed tomography and magnetic resonance imaging for liver cancer delineation using deformable image registration. Int J Radiat Oncol Biol Phys, 2006, 66(3):780-791.
[12] Price TR, Perkins SM, Sandrasegara NK, et al. Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma. Cancer, 2012, 118(12):3191-3198.
[13] Wang H, Krishnan S, Wang X, et al. Improving soft-tissue contrast in four-dimensional computed tomography images of liver cancer patients using a deformable image registration method. Int J Radiat Oncol Biol Phys, 2008, 72(1):201-209.
[14] Jang SS, Huh GJ, Park SY, et al. Usefulness of target delineation based on the two extreme phases of a four-dimensional computed tomography scan in stereotactic body radiation therapy for lung cancer. Thoracic Cancer, 2015, 6(3):239-246.
[15] Mahmoud B, Elkholy SF, Nabeel MM, et al. Role ofMRI in the assessment of treatment response after radiofrequency and microwave ablation therapy for hepatocellular carcinoma. Egypt J Radiol Nucl Med, 2016, 47(2):377-385.
[16] 黄付静, 马长升, 王若峥, 等. 4DCT与MR图像变形配准确定原发性肝癌放疗靶区的应用研究. 中华放射肿瘤学杂志, 2017, 26(5):555-559.
[17] Velec M, Moseley JL, Craig T, et al. Effect of breathing motion on radiotherapy dose accumulation in the abdomen using deformable registration. Int J Radiat Oncol Biol Phys, 2011, 80(1):265-272.
[18] Wijesooriya K, Weiss E, Dill V, et al. Quantifying the accuracy of automated structure segmentation in 4d ct images using a deformable image registration algorithm. Medl Phys, 2008, 35(4):1251-1260.
[19] Fernandes AT, Apisarnthanarax S, Yin L, et al. Comparative assessment of liver tumor motion using cine-magnetic resonance imaging versus 4-dimensional computed tomography. Int J Radiat Oncol Biol Phys, 2015, 91(5):1034-1040.
[20] Pukala J, Johnson PB, Shah AP, et al. Benchmarking of five commercial deformable image registration algorithms for head and neck patients. J Appl Clin Med Phys, 2016, 17(3):25-40.

MRI与4DCT联合指导勾画原发性肝癌患者放疗靶区初步研究^*

A pilot study of MR and 4DCT images in the delineation of target area in patients with primary liver cancer undergoing first radiotherapy

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	王宝锋, 马彦高, 李义, 曾宪强, 周进学. 增强MRI扫描在乙型肝炎肝硬化背景下对原发性肝癌的诊断价值分析^*[J]. 实用肝脏病杂志, 2022, 25(4): 554-557.
[2]	刘浩, 周菲菲, 孙好凯, 刘永刚. 基于CBCT的三维重建技术用于TACE术治疗原发性肝癌患者对肿瘤供血动脉识别的价值^*[J]. 实用肝脏病杂志, 2022, 25(4): 563-566.
[3]	魏博文, 任峥, 张亮, 汪伟. 增强CT扫描评估TACE术治疗的原发性肝癌患者效果分析[J]. 实用肝脏病杂志, 2022, 25(4): 603-604.
[4]	胡勇军, 汪磊, 刘宁, 晏华军. 间歇性全入肝血流阻断与区域性入肝血流阻断腹腔镜肝切除术治疗原发性肝癌患者术后恢复研究^*[J]. 实用肝脏病杂志, 2022, 25(3): 411-414.
[5]	孙浩, 曹丽, 曹林, 龙云. 腹腔镜肝切除术治疗原发性肝癌患者应用氢吗啡酮联合纳布啡静脉自控镇痛控制疼痛作用研究^*[J]. 实用肝脏病杂志, 2022, 25(3): 415-418.
[6]	邱云, 杨玫, 薛红红. TACE联合超声引导下微波消融治疗特殊部位原发性肝癌患者疗效研究^*[J]. 实用肝脏病杂志, 2022, 25(3): 419-422.
[7]	刘慧敏, 刘晓利, 王欣惠, 杨志云, 江宇泳. 原发性肝癌患者外周血CD4+T、CD8+T、Tc17、Th17和Treg淋巴细胞的变化及其意义^*[J]. 实用肝脏病杂志, 2022, 25(2): 255-258.
[8]	王婵, 沈长清, 吴晓琼, 邓程伟, 谢文蕊. 表柔比星药物洗脱微球肝动脉化疗栓塞术治疗不可手术切除的原发性肝癌患者临床疗效和安全性分析[J]. 实用肝脏病杂志, 2022, 25(2): 259-262.
[9]	谭玉英, 张鑫, 张娟子, 张山西. MRI联合血清GPC3水平鉴别肝脏结节性增生病灶临床应用价值研究^*[J]. 实用肝脏病杂志, 2022, 25(1): 88-91.
[10]	周颜, 李国平, 邓俊, 杨美蓉, 吴晓霞, 张英, 朱宏英, 陈卫. 射频消融术治疗原发性肝癌患者接受胸腺素α₁维持治疗临床价值探讨^*[J]. 实用肝脏病杂志, 2021, 24(6): 907-910.
[11]	杨永汉, 路萍, 孟庆宁, 张枫婕. 增强MRI T1 mapping定量评估慢性乙型肝炎患者肝纤维化程度效能分析[J]. 实用肝脏病杂志, 2021, 24(5): 685-688.
[12]	梁旭, 刘圆圆, 杨学刚, 任静. 基于2018年版肝脏影像报告数据系统对比分析CT和MRI诊断肝细胞癌的效能^*[J]. 实用肝脏病杂志, 2021, 24(5): 725-728.
[13]	彭光明, 葛尚, 井桂银. 自适应性统计迭代重建联合低管电压提高肝细胞癌患者肝脏CT三期增强扫描图像质量研究[J]. 实用肝脏病杂志, 2021, 24(5): 737-740.
[14]	徐燕, 李啸天, 刘慧, 陈渝晖. 管壁增厚型胆囊癌患者MRI影像学特征分析^*[J]. 实用肝脏病杂志, 2021, 24(5): 757-760.
[15]	欧南, 魏梅, 王劲, 彭正伟. 应用MRI多回波水脂分离技术评估非酒精性脂肪性肝病患者肝脏脂肪含量效能研究^*[J]. 实用肝脏病杂志, 2021, 24(4): 508-511.